share_log

Why Anhui Hongyu Wuzhou Medical ManufacturerLTD's (SZSE:301234) Shaky Earnings Are Just The Beginning Of Its Problems

Why Anhui Hongyu Wuzhou Medical ManufacturerLTD's (SZSE:301234) Shaky Earnings Are Just The Beginning Of Its Problems

爲什麼安徽宏宇五洲醫療器械製造有限公司(SZSE: 301234)不穩定的收益只是問題的開始
Simply Wall St ·  04/22 19:47

The market wasn't impressed with the soft earnings from Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) recently. We did some analysis, and found that there are some reasons to be cautious about the headline numbers.

安徽宏宇五洲醫療器械製造有限公司的疲軟收益並沒有給市場留下深刻的印象。, LTD.(SZSE: 301234) 最近。我們做了一些分析,發現有一些理由對標題數字持謹慎態度。

earnings-and-revenue-history
SZSE:301234 Earnings and Revenue History April 22nd 2024
SZSE: 301234 2024 年 4 月 22 日的收益和收入記錄

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Anhui Hongyu Wuzhou Medical ManufacturerLTD's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥4.6m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. If Anhui Hongyu Wuzhou Medical ManufacturerLTD doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

對於任何想了解安徽宏宇五洲醫療製造有限公司在法定數字之外的利潤的人來說,值得注意的是,在過去的十二個月中,從價值460萬元人民幣的不尋常物品中獲得了法定利潤。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。考慮到這個名字,這並不奇怪。如果安徽宏宇五洲醫療器械製造有限公司不認爲這種捐款重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Anhui Hongyu Wuzhou Medical ManufacturerLTD.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對安徽宏宇五洲醫藥製造有限公司的資產負債表分析

Our Take On Anhui Hongyu Wuzhou Medical ManufacturerLTD's Profit Performance

我們對安徽宏宇五洲醫療器械製造有限公司盈利表現的看法

Arguably, Anhui Hongyu Wuzhou Medical ManufacturerLTD's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Anhui Hongyu Wuzhou Medical ManufacturerLTD's true underlying earnings power is actually less than its statutory profit. Sadly, its EPS was down over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. At Simply Wall St, we found 2 warning signs for Anhui Hongyu Wuzhou Medical ManufacturerLTD and we think they deserve your attention.

可以說,安徽宏宇五洲醫療器械製造有限公司的法定收益被提高利潤的不尋常項目所扭曲。因此,在我們看來,安徽宏宇五洲醫療製造有限公司的真正基礎盈利能力實際上可能低於其法定利潤。不幸的是,在過去的十二個月中,其每股收益有所下降。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。考慮到這一點,除非我們對風險有透徹的了解,否則我們不會考慮投資股票。在Simply Wall St,我們發現了安徽紅宇五洲醫療器械製造有限公司的兩個警告標誌,我們認爲它們值得你關注。

Today we've zoomed in on a single data point to better understand the nature of Anhui Hongyu Wuzhou Medical ManufacturerLTD's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我們放大了單一數據點,以更好地了解安徽宏宇五洲醫療器械製造有限公司利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論